Risk of reactive cutaneous capillary endothelial proliferation induced by camrelizumab in patients with non-small cell lung cancer: a retrospective study.

Authors:
He X; Fang J; Yu P; Hu W; Zhang Q and 4 more

Journal:
J Thorac Dis

Publication Year: 2023

DOI:
10.21037/jtd-23-1144

PMCID:
PMC10797357

PMID:
38249866

Journal Information

Full Title: J Thorac Dis

Abbreviation: J Thorac Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Respiratory System

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1144/coif). X.B. reports funding from the Bethune Charitable Foundation Pharmaceutical Research Capacity Building Project (No. Z04JKM2021005) and the Clinical Pharmacy Innovation Institute, Shanghai Jiao Tong University School of Medicine (No. CXYJY2019MS004). The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by the Bethune Charitable Foundation Pharmaceutical Research Capacity Building Project ( No. Z04JKM2021005 ) and the Clinical Pharmacy Innovation Institute, Shanghai Jiao Tong University School of Medicine ( No. CXYJY2019MS004 )."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025